{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:19:29Z","timestamp":1791001169184,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.exer.2020.108130","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T11:20:24Z","timestamp":1593602424000},"page":"108130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Intravitreal enzyme replacement preserves retinal structure and function in canine CLN2 neuronal ceroid lipofuscinosis"],"prefix":"10.1016","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7607-2639","authenticated-orcid":false,"given":"Rebecca E.H.","family":"Whiting","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline W.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella P.","family":"Vansteenkiste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0135-7354","authenticated-orcid":false,"given":"Katherine","family":"Bibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3231-3194","authenticated-orcid":false,"given":"Grace","family":"Robinson Kick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilani J.","family":"Castaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5731-1075","authenticated-orcid":false,"given":"John","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundeep","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin L.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2020.108130_bib1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ymgme.2006.02.016","article-title":"A frame shift mutation in canine TPP1 (the ortholog of human CLN2) in a juvenile Dachshund with neuronal ceroid lipofuscinosis","volume":"89","author":"Awano","year":"2006","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.exer.2020.108130_bib2","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1111\/bph.14024","article-title":"Principles of pharmacology in the eye","volume":"174","author":"Awwad","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exer.2020.108130_bib3","first-page":"5397","article-title":"Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis","volume":"9","author":"Ba","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.exer.2020.108130_bib4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/eye.2009.143","article-title":"Bilateral intraocular inflammation after intravitreal bevacizumab in Behcet's disease","volume":"24","author":"Bae","year":"2010","journal-title":"Eye"},{"key":"10.1016\/j.exer.2020.108130_bib5","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00417-007-0754-7","article-title":"Intraocular inflammation following intravitreal injection of bevacizumab","volume":"246","author":"Bakri","year":"2008","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108130_bib6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0195-5616(94)50080-9","article-title":"Allergic- and immunologic-mediated diseases of the eye and adnexae","volume":"24","author":"Bistner","year":"1994","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"issue":"Suppl. 1","key":"10.1016\/j.exer.2020.108130_bib7","first-page":"S9","article-title":"The endosomal network","volume":"47","author":"Brooks","year":"2009","journal-title":"Int. J. Clin. Pharmacol. Therapeut."},{"key":"10.1016\/j.exer.2020.108130_bib8","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1172\/JCI42440","article-title":"A look at autoimmunity and inflammation in the eye","volume":"120","author":"Caspi","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.exer.2020.108130_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000119871","article-title":"Mouse models of experimental autoimmune uveitis","volume":"40","author":"Caspi","year":"2008","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.exer.2020.108130_bib10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/mt.2008.9","article-title":"Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Chang","year":"2008","journal-title":"Mol. Ther.: J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.exer.2020.108130_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/eye.2016.177","article-title":"Doyne lecture 2016: intraocular health and the many faces of inflammation","volume":"31","author":"Dick","year":"2017","journal-title":"Eye"},{"key":"10.1016\/j.exer.2020.108130_bib12","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1080\/17425255.2017.1404987","article-title":"Pharmacokinetics of intravitreal anti-VEGF drugs in vitrectomized versus non-vitrectomized eyes","volume":"13","author":"Edington","year":"2017","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.exer.2020.108130_bib13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2174\/1566524015666150731095426","article-title":"Ocular inflammatory diseases: molecular pathogenesis and immunotherapy","volume":"15","author":"Egwuagu","year":"2015","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.exer.2020.108130_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10633-013-9388-8","article-title":"Guidelines for clinical electroretinography in the dog: 2012 update","volume":"127","author":"Ekesten","year":"2013","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108130_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/rej.2009.0920","article-title":"New strategies for enzyme replacement therapy for lysosomal storage diseases","volume":"13","author":"Grubb","year":"2010","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.exer.2020.108130_bib16","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1074\/jbc.M806943200","article-title":"Crystal structure and autoactivation pathway of the precursor form of human tripeptidyl-peptidase 1, the enzyme deficient in late infantile ceroid lipofuscinosis","volume":"284","author":"Guhaniyogi","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2020.108130_bib17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2217\/imt.16.5","article-title":"Aflibercept for the treatment of diabetic macular edema","volume":"8","author":"Harkins","year":"2016","journal-title":"Immunotherapy"},{"key":"10.1016\/j.exer.2020.108130_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12712","article-title":"Immune modulation by mesenchymal stem cells","volume":"53","author":"Jiang","year":"2020","journal-title":"Cell Prolif"},{"key":"10.1016\/j.exer.2020.108130_bib19","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1167\/iovs.08-1712","article-title":"Retinal pathology in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"49","author":"Katz","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.108130_bib20","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/jnr.23423","article-title":"Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease)","volume":"92","author":"Katz","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.exer.2020.108130_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jns.2017.05.009","article-title":"Cervical spinal cord and motor unit pathology in a canine model of SOD1-associated amyotrophic lateral sclerosis","volume":"378","author":"Katz","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.exer.2020.108130_bib22","doi-asserted-by":"crossref","first-page":"313ra180","DOI":"10.1126\/scitranslmed.aac6191","article-title":"AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease","volume":"7","author":"Katz","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.exer.2020.108130_bib23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archopht.120.3.338","article-title":"Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment","volume":"120","author":"Krzystolik","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108130_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00281-014-0433-9","article-title":"Autoimmune and autoinflammatory mechanisms in uveitis","volume":"36","author":"Lee","year":"2014","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.exer.2020.108130_bib25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/geno.1998.5328","article-title":"Structural organization and sequence of CLN2, the defective gene in classical late infantile neuronal ceroid lipofuscinosis","volume":"50","author":"Liu","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.exer.2020.108130_bib26","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s40265-017-0771-8","article-title":"Cerliponase alfa: first global approval","volume":"77","author":"Markham","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.exer.2020.108130_bib27","doi-asserted-by":"crossref","first-page":"928123","DOI":"10.1155\/2012\/928123","article-title":"Sterile endophthalmitis after intravitreal injections","volume":"2012","author":"Marticorena","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.exer.2020.108130_bib28","doi-asserted-by":"crossref","first-page":"xli","DOI":"10.1016\/j.ajo.2017.12.019","article-title":"Evolution of intravitreal therapy for retinal diseases-from CMV to CNV: the LXXIV Edward Jackson Memorial lecture","volume":"191","author":"Martin","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108130_bib29","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","article-title":"Genetics of the neuronal ceroid lipofuscinoses (Batten disease)","volume":"1852","author":"Mole","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.exer.2020.108130_bib30","series-title":"The Neuronal Ceroid Lipofuscinoses (Batten Disease)","author":"Mole","year":"2011"},{"key":"10.1016\/j.exer.2020.108130_bib31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejpb.2015.04.033","article-title":"Evaluation of protein drug stability with vitreous humor in a novel ex-vivo intraocular model","volume":"95","author":"Patel","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.exer.2020.108130_bib32","first-page":"49","article-title":"The effect of lens-induced uveitis on the success of extracapsular cataract extraction: a retrospective study of 65 lens removals in the dog","volume":"22","author":"Paulsen","year":"1986","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"10.1016\/j.exer.2020.108130_bib33","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.drudis.2016.10.015","article-title":"Protein delivery to the back of the eye: barriers, carriers and stability of anti-VEGF proteins","volume":"22","author":"Radhakrishnan","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.exer.2020.108130_bib34","doi-asserted-by":"crossref","first-page":"151041","DOI":"10.1016\/j.ejcb.2019.04.002","article-title":"Mesenchymal stem cell therapy for the treatment of inflammatory diseases: challenges, opportunities, and future perspectives","volume":"98","author":"Regmi","year":"2019","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.exer.2020.108130_bib35","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","article-title":"Study of intraventricular cerliponase alfa for CLN2 disease","volume":"378","author":"Schulz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2020.108130_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpn.2017.04.989","article-title":"Intracerebroventricular cerliponase alfa for children with CLN2 disease: interim results from an ongoing phase 2 extension study","volume":"21","author":"Schulz","year":"2017","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.exer.2020.108130_bib37","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1126\/science.277.5333.1802","article-title":"Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis","volume":"277","author":"Sleat","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.exer.2020.108130_bib38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.exer.2016.09.003","article-title":"Intravitreal implantation of TPP1-transduced stem cells delays retinal degeneration in canine CLN2 neuronal ceroid lipofuscinosis","volume":"152","author":"Tracy","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2020.108130_bib39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000492681","article-title":"Noninfectious inflammatory response following intravitreal bevacizumab injections: description of a cluster of cases in two centers and a review of the literature","volume":"240","author":"Trivizki","year":"2018","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.exer.2020.108130_bib40","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/17425247.2016.1213240","article-title":"Current advances in the treatment of neovascular age-related macular degeneration","volume":"14","author":"Villegas","year":"2017","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.exer.2020.108130_bib41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ymgme.2014.09.004","article-title":"Nonclinical evaluation of CNS-administered TPP1 enzyme replacement in canine CLN2 neuronal ceroid lipofuscinosis","volume":"114","author":"Vuillemenot","year":"2015","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.exer.2020.108130_bib42","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1208\/s12248-017-0128-y","article-title":"Advancements in understanding immunogenicity of biotherapeutics in the intraocular space","volume":"19","author":"Wakshull","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.exer.2020.108130_bib43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.exer.2016.03.023","article-title":"Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease","volume":"146","author":"Whiting","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2020.108130_bib44","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.exer.2014.06.008","article-title":"Enzyme replacement therapy delays pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"125","author":"Whiting","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2020.108130_bib45","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.exer.2013.10.006","article-title":"Pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"116","author":"Whiting","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2020.108130_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.exer.2015.02.012","article-title":"Multifocal retinopathy in Dachshunds with CLN2 neuronal ceroid lipofuscinosis","volume":"134","author":"Whiting","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2020.108130_bib47","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.ophtha.2008.05.007","article-title":"Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration","volume":"115","author":"Wickremasinghe","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2020.108130_bib48","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/030098588702400613","article-title":"The pathology of lens-induced uveitis in dogs","volume":"24","author":"Wilcock","year":"1987","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.exer.2020.108130_bib49","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1042\/BST0381484","article-title":"Current therapies for the soluble lysosomal forms of neuronal ceroid lipofuscinosis","volume":"38","author":"Wong","year":"2010","journal-title":"Biochem. Soc. Trans."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483520303882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483520303882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:08:59Z","timestamp":1757999339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483520303882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":49,"alternative-id":["S0014483520303882"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2020.108130","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreal enzyme replacement preserves retinal structure and function in canine CLN2 neuronal ceroid lipofuscinosis","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2020.108130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108130"}}